Cardinal Health's (CAH) performance has been mixed as the stock sees both rises and declines against the market trends. The company is highlighted for its strong value and long-term outlook. Investors who invested in CAH three years ago have seen a significant increase of 149% in their investments. CAH stock has experienced minor fluctuations, moving +-0.08%, and in some cases dipping while the market grew. The company has also been able to beat earnings estimates and has boosted guidance following strong drug sales. Its acquisition profile has been active, with notable mentions including the purchase of Integrated Oncology Network for $1.12 billion and Specialty Networks. Following its Q4 results, CAH has improved its FY25 outlook. Despite these positives, the business lost its OptumRx contracts, and the company's medical unit profit forecast has been lowered. The business announced the location of a pharmaceutical distribution center for over-the-counter products and celebrated the opening of a distribution center in Greenville, South Carolina. The company's stock performance is slightly under local competitors.
Cardinal Health CAH News Analytics from Wed, 31 Jan 2024 08:00:00 GMT to Sat, 26 Oct 2024 07:42:27 GMT -
Rating 7
- Innovation -3
- Information 8
- Rumor 1
